Industry
Linear Clinical Research
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed trials have results
Key Signals
1 with results
Enrollment Performance
Analytics
Phase 1
4(80.0%)
Phase 3
1(20.0%)
5Total
Phase 1(4)
Phase 3(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT05202379Phase 1Completed
CC-42344 Safety Study in Healthy Participants
Role: collaborator
NCT02616445Phase 1Completed
Phase I MAD, Fed-Fasted, CSF Study of UE2343 in Healthy Subjects
Role: collaborator
NCT03493191Phase 1Completed
A Single Dose Study of SHR0410 in Healthy Male Participants
Role: collaborator
NCT02850718Phase 3Completed
A Pivotal Study of the Bioequivalence of Oral Viagra® and a Test Sublingual Sildenafil Wafer
Role: collaborator
NCT01748838Phase 1Completed
Phase 1 Study Assessing the Safety and Tolerability of CTX-4430
Role: collaborator
All 5 trials loaded